脑部放疗，上午比下午敏感许多！) u. p: b/ u4 ? s" D
) K" `) |* ]! Z# ^0 |
) [5 ^: ^- f) P/ z' KCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. }2 W/ S- d6 K, [
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?% B% L4 m9 o9 m. f( L3 _' M
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
& P2 |7 m( c9 m0 \SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.$ ?) K- Y8 g' x$ p) p: X' e+ V
4 c ~: Y+ [. e+ U+ x
Abstract
- Q- z( k; l4 _BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
. B9 Z% O3 ~+ F/ k0 [4 D; v( U
# X5 s8 d, ~. k0 P h9 hMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.: N q M9 X% k$ q" t
2 i2 e! |9 M7 G2 S' I5 C" f' [# z4 W
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).% Q r) S, p5 q1 _3 d
) C; P' R9 P* o, X2 [* {& ^# h
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
0 J8 ?1 q! @. c, m S8 q/ V- F& K8 [# B7 g9 R2 P- q
|
11011102001537 )
显身卡
